Parkman Healthcare Partners LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 65 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$2,050,000
+27.0%
211,385
+40.6%
0.45%
+19.5%
Q1 2021$1,614,000
-33.3%
150,304
-8.7%
0.38%
-39.5%
Q4 2020$2,421,000
-54.6%
164,585
-56.1%
0.62%
-56.1%
Q3 2020$5,330,000
+119.6%
375,063
+25.0%
1.41%
+106.3%
Q2 2020$2,427,000
+41.4%
300,000
-29.4%
0.68%
-14.1%
Q1 2020$1,717,000425,0000.80%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 701,138$4,067,0000.67%
Matrix Capital Management Company, LP 2,288,560$13,274,0000.33%
NEA Management Company, LLC 1,250,000$7,250,0000.31%
Stanley-Laman Group, Ltd. 139,403$809,0000.20%
Cormorant Asset Management, LP 500,000$2,900,0000.19%
Tekla Capital Management LLC 468,399$2,717,0000.10%
Wealth Alliance Advisory Group, LLC 21,800$126,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 175,339$1,007,0000.03%
Artal Group S.A. 150,000$870,0000.02%
Baker Brothers Advisors 505,262$2,931,0000.02%
View complete list of TRILLIUM THERAPEUTICS INC shareholders